Embecta Corp. (EMBC)
5.685
-0.06
(-1.13%)
USD |
NASDAQ |
Oct 09, 16:00
5.75
+0.06
(+1.14%)
After-Hours: 20:00
Embecta Free Cash Flow : 164.60M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 164.60M |
| March 31, 2026 | 204.70M |
| December 31, 2025 | 205.80M |
| September 30, 2025 | 182.40M |
| June 30, 2025 | 132.30M |
| March 31, 2025 | 39.70M |
| December 31, 2024 | 28.90M |
| September 30, 2024 | 19.90M |
| June 30, 2024 | 13.70M |
| Date | Value |
|---|---|
| March 31, 2024 | 9.40M |
| December 31, 2023 | -30.30M |
| September 30, 2023 | 41.20M |
| June 30, 2023 | 70.20M |
| March 31, 2023 | 113.80M |
| December 31, 2022 | 309.40M |
| September 30, 2022 | 388.20M |
| June 30, 2022 | 410.90M |
| March 31, 2022 | 505.40M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Artivion, Inc. | -9.157M |
| Abbott Laboratories | 7.824B |
| AngioDynamics, Inc. | -3.873M |
| Alphatec Holdings, Inc. | -5.739M |
| AtriCure, Inc. | 53.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 41.80M |
| Cash from Investing (Quarterly) | -129.50M |
| Cash from Financing (Quarterly) | 112.40M |
| Free Cash Flow Per Share (Quarterly) | 0.6956 |
| Free Cash Flow to Equity (Quarterly) | -88.50M |
| Free Cash Flow to Firm (Quarterly) | 58.97M |
| Free Cash Flow Yield | 49.08% |